Molecular Profile and Proliferative Responses of Rat Lymphatic Endothelial Cells in Culture
- 1 September 2006
- journal article
- Published by Mary Ann Liebert Inc in Lymphatic Research and Biology
- Vol. 4 (3) , 119-142
- https://doi.org/10.1089/lrb.2006.4.119
Abstract
Lymphangiogenesis plays an important role in metastasis of many solid tumors. To study lymphangiogenesis under controlled conditions, an in vitro model is needed. The goal of this work was to establish such an in vitro model by determining a molecular profile of rat mesenteric lymphatic endothelial cells (RMLEC) and characterizing their proliferative responses to angiogenic and lymphangiogenic factors, such as vascular endothelial growth factor A and C (VEGF-A and VEGF-C). RMLEC strongly expressed most lymphatic-specific markers, including Prox-1, LYVE-1, and VEGFR-3. Proliferation of RMLEC was serum and heparin dependent. In the presence of low (2%) serum concentration, exogenously added VEGF-A and VEGFC stimulated RMLEC in a linear and dose-dependent manner. This effect was abrogated by anti-VEGF-A and VEGF-C antibodies, as well as by soluble Tie-2 and Flt-4 fusion proteins. Abrogation was reversed by VEGF-A, suggesting that this factor as an important regulator of lymphangiogenesis. Cultured RMLEC preserved a molecular profile consistent with the phenotype of lymphatic endothelium in vivo and respond to either VEGF-A or VEGF-C factors. VEGFA was able to rescue RMLEC proliferation inhibited by a neutralizing VEGF-C antibody or soluble Tie-2 fusion protein. These results support the existence of cross-talk among angiogenic and lymphangiogenic factors. This work established experimental conditions that allow in vitro modeling of lymphatic endothelial responses to lymphangiogenic regulators. Preliminary results using this model suggest that VEGF-A, VEGF-C, and angiopoietins work in concert to promote lymphangiogenesis in vivo.Keywords
This publication has 93 references indexed in Scilit:
- Generation and characterization of a mouse lymphatic endothelial cell lineCell and tissue research, 2006
- Increased Angiogenesis and Lymphangiogenesis in Inflammatory versus Noninflammatory Breast Cancer by Real-Time Reverse Transcriptase-PCR Gene Expression QuantificationClinical Cancer Research, 2004
- Angiopoietins in tumours: the angiogenic switchThe Journal of Pathology, 2004
- VEGF‐A promotes tissue repair‐associated lymphatic vessel formation via VEGFR‐2 and the α1β1 and α2β1 integrinsThe FASEB Journal, 2004
- Transcriptional regulation of human angiopoietin-2 by transcription factor Ets-1Biochemical and Biophysical Research Communications, 2004
- IL-19 Molecular mechanisms of skin angiogenesis and lymphangiogenesis and their significance for melanoma progressionPigment Cell Research, 2003
- Ligand-induced Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3) Heterodimerization with VEGFR-2 in Primary Lymphatic Endothelial Cells Regulates Tyrosine Phosphorylation SitesJournal of Biological Chemistry, 2003
- Lymphangiogenic growth factors, receptors and therapiesThrombosis and Haemostasis, 2003
- The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissuesThe FASEB Journal, 2002
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002